David C. Mis

Array ( [id] => 10938848 [patent_doc_number] => 20140341870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-20 [patent_title] => 'BIOCOMPOSITE FOR REGENERATION OF INJURED TISSUE AND ORGANS, A KIT FOR MAKING THE BIOCOMPOSITE, A METHOD OF MAKING THE BIOCOMPOSITE AND A METHOD OF TREATING INJURIES' [patent_app_type] => utility [patent_app_number] => 14/369008 [patent_app_country] => US [patent_app_date] => 2012-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6441 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14369008 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9190964 [patent_doc_number] => 20130330279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-12 [patent_title] => 'NANOPARTICLE MEDIATED GENE THERAPY, DIAGNOSTIC PRODUCTS AND THERAPEUTIC PRODUCTS FOR BREAST CANCER' [patent_app_type] => utility [patent_app_number] => 13/726018 [patent_app_country] => US [patent_app_date] => 2012-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8079 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13726018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9575512 [patent_doc_number] => 08765926 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-01 [patent_title] => 'Multidimensional supramolecular structures essentially made of assembled i-motif tetramers' [patent_app_type] => utility [patent_app_number] => 13/716851 [patent_app_country] => US [patent_app_date] => 2012-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 19 [patent_no_of_words] => 12516 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13716851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12960325 [patent_doc_number] => 09872911 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-23 [patent_title] => Alpha-aminoamidine polymers and uses thereof [patent_app_type] => utility [patent_app_number] => 14/364028 [patent_app_country] => US [patent_app_date] => 2012-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 70 [patent_figures_cnt] => 60 [patent_no_of_words] => 28988 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 267 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14364028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9307239 [patent_doc_number] => 20140045913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-13 [patent_title] => 'LIPID NANO PARTICLES COMPRISING COMBINATION OF CATIONIC LIPID' [patent_app_type] => utility [patent_app_number] => 13/711909 [patent_app_country] => US [patent_app_date] => 2012-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 31821 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13711909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9295398 [patent_doc_number] => 20140039032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-06 [patent_title] => 'LIPID NANO PARTICLES COMPRISING CATIONIC LIPID FOR DRUG DELIVERY SYSTEM' [patent_app_type] => utility [patent_app_number] => 13/711922 [patent_app_country] => US [patent_app_date] => 2012-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 24972 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13711922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8841162 [patent_doc_number] => 20130136790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-30 [patent_title] => 'LIPOSOMES WITH IMPROVED DRUG RETENTION FOR TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 13/709005 [patent_app_country] => US [patent_app_date] => 2012-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 5375 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13709005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8841297 [patent_doc_number] => 20130136925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-30 [patent_title] => 'DNA-LINKED NANOPARTICLE BUILDING BLOCKS FOR NANOSTRUCTURE ASSEMBLY AND METHODS OF PRODUCING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/690305 [patent_app_country] => US [patent_app_date] => 2012-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6740 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13690305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8821051 [patent_doc_number] => 20130122096 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-16 [patent_title] => 'COMPOSITIONS FOR DRUG DELIVERY AND METHODS OF MANUFACTURING AND USING SAME' [patent_app_type] => utility [patent_app_number] => 13/676540 [patent_app_country] => US [patent_app_date] => 2012-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 14384 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13676540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8976721 [patent_doc_number] => 20130210151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'ENDONUCLEASE FOR GENOME EDITING' [patent_app_type] => utility [patent_app_number] => 13/671452 [patent_app_country] => US [patent_app_date] => 2012-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 19324 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13671452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9685926 [patent_doc_number] => 20140242690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-28 [patent_title] => 'CYSTIC FIBROSIS TREATMENT' [patent_app_type] => utility [patent_app_number] => 14/354501 [patent_app_country] => US [patent_app_date] => 2012-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 33532 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14354501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9685283 [patent_doc_number] => 20140242046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-28 [patent_title] => 'INHIBITION AND ENHANCEMENT OF REPROGRAMMING BY CHROMATIN MODIFYING ENZYMES' [patent_app_type] => utility [patent_app_number] => 14/351717 [patent_app_country] => US [patent_app_date] => 2012-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 34000 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14351717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9685416 [patent_doc_number] => 20140242180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-28 [patent_title] => 'NANOPARTICLES FOR CONTROLLING BLEEDING AND DRUG DELIVERY' [patent_app_type] => utility [patent_app_number] => 14/351807 [patent_app_country] => US [patent_app_date] => 2012-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16628 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14351807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8767131 [patent_doc_number] => 20130095167 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-18 [patent_title] => 'CUSTOMIZED COMPOSITIONS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/649620 [patent_app_country] => US [patent_app_date] => 2012-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 27892 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13649620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9297895 [patent_doc_number] => RE044760 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2014-02-11 [patent_title] => 'Antisense modulation of apolipoprotein B-expression' [patent_app_type] => reissue [patent_app_number] => 13/629214 [patent_app_country] => US [patent_app_date] => 2012-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66482 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13629214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8767076 [patent_doc_number] => 20130095113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-18 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/625597 [patent_app_country] => US [patent_app_date] => 2012-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 37308 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13625597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8723001 [patent_doc_number] => 20130074218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-21 [patent_title] => 'METHOD FOR OPTIMISING GENE EXPRESSION USING SYNONYMOUS CODON OPTIMISATION' [patent_app_type] => utility [patent_app_number] => 13/619345 [patent_app_country] => US [patent_app_date] => 2012-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15442 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13619345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8950536 [patent_doc_number] => 20130196317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'METHODS FOR DETECTING FETAL NUCLEIC ACIDS AND DIAGNOSING FETAL ABNORMALITIES' [patent_app_type] => utility [patent_app_number] => 13/614391 [patent_app_country] => US [patent_app_date] => 2012-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11318 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13614391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8708661 [patent_doc_number] => 20130065950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-14 [patent_title] => 'MODIFIED OLIGONUCLEOTIDES FOR TELOMERASE INHIBITION' [patent_app_type] => utility [patent_app_number] => 13/590511 [patent_app_country] => US [patent_app_date] => 2012-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 14238 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13590511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8670878 [patent_doc_number] => 20130045416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-21 [patent_title] => 'GOLD MICRO- AND NANOTUBES, THEIR SYNTHESIS AND USE' [patent_app_type] => utility [patent_app_number] => 13/586511 [patent_app_country] => US [patent_app_date] => 2012-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7104 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13586511 [rel_patent_id] =>[rel_patent_doc_number] =>)